Treatment Resistance Following Anti-cancer Therapies
Public ClinicalTrials.gov record NCT04436120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
TREATMENT RESISTANCE FOLLOWING ANTI-CANCER THERAPIES (TRANSLATE)
Study identification
- NCT ID
- NCT04436120
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 38 participants
Conditions and interventions
Conditions
Interventions
- De novo tumor tissue biopsy Procedure
- Research blood draws Procedure
Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 12, 2019
- Primary completion
- Dec 13, 2020
- Completion
- Dec 13, 2020
- Last update posted
- Dec 2, 2024
2019 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 6
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center, P.C. | Daphne | Alabama | 36526 | — |
| Southern Cancer Center, PC | Mobile | Alabama | 36607 | — |
| Southern Cancer Center, PC | Mobile | Alabama | 36608 | — |
| Alaska Urological Institute dba Alaska Clinical Research Center | Anchorage | Alaska | 99503 | — |
| Arizona Oncology Associates, PC-HOPE | Tucson | Arizona | 85704 | — |
| Arizona Oncology Associates, PC - HOPE | Tucson | Arizona | 85711 | — |
| The Oncology Institute of Hope Innovation | Glendale | California | 91204 | — |
| The Oncology Institute of Hope Innovation | Long Beach | California | 90805 | — |
| UCI Medical Center-Chao Family Comprehensive Cancer Center | Orange | California | 92868-3201 | — |
| The Oncology Institute of Hope Innovation | Santa Ana | California | 92705 | — |
| Sansum Clinic | Santa Barbara | California | 93105 | — |
| Sansum Clinic | Solvang | California | 93463 | — |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90602 | — |
| ICRI-Administrative and Supplies Only | Whittier | California | 90603 | — |
| Woodlands Medical Specialists PA | Pensacola | Florida | 32503 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04436120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04436120 live on ClinicalTrials.gov.